StockData
Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc. (CTKB) stock

CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/309% below fair value
$5.70+0.07 (+1.24%)

Close on Nov 17, 2026Market cap $740.91MP/E –Yield –

Cytek Biosciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Cytek Biosciences's EV/EBITDA was 695.6× on Jan 31, 2023, against 95.6× a year earlier.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 2023695.6×+134.5
2022Dec 30, 2022561.1×+451.2
2021Dec 31, 2021109.9×–

More Cytek Biosciences figures

See a number that looks wrong?